Corbion/€CRBN

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Corbion

Corbion NV, trading under the ticker CRBN, is a Netherlands-based company specializing in biochemical ingredients. Operating within the biochemical sector, Corbion offers an extensive range of products including lactic acid and its derivatives, as well as other bio-based chemicals for various industries. Founded in 1919, the company has grown to serve a global market, providing ingredients and solutions for food, biochemical applications, and more.

Ticker

€CRBN
Sector

Primary listing

AEX

Industry

Chemicals

Employees

2,407

ISIN

NL0010583399

Corbion Metrics

BasicAdvanced
€1.1B
5.75
€3.24
1.09
€0.64
3.44%

What the Analysts think about Corbion

Analyst ratings (Buy, Hold, Sell) for Corbion stock.

Bulls say / Bears say

Corbion's acquisition of Novotech's bread improver business in August 2024 strengthens its position in the Indian market, potentially driving revenue growth. (corbion.com)
The company's €20 million share buyback program, completed in July 2024, reflects management's confidence in Corbion's financial health and may enhance shareholder value. (corbion.com)
Analyst sentiment remains positive, with Barclays maintaining a 'Buy' rating and a price target of €25 as of November 2024, indicating potential upside. (tipranks.com)
Berenberg downgraded Corbion's stock from 'Buy' to 'Hold' in October 2024, citing limited potential for earnings per share upgrades following a 25% rally. (investing.com)
The company's restructuring plan announced in January 2024, involving job cuts and centralization of functions, led to a share price decline, reflecting investor concerns about execution risks. (bloomberglaw.com)
Corbion's dividend payout ratio exceeded 200% of free cash flow over the past 12 months, raising concerns about the sustainability of its dividend payments. (simplywall.st)
Data summarised monthly by Lightyear AI. Last updated on 5 Jun 2025.

Corbion Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Corbion Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €CRBN

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs